Triple

T2857447
Position Surface form Disambiguated ID Type / Status
Subject Lou Gehrig E63235 entity
Predicate diseaseEponym P36445 FINISHED
Object Lou Gehrig's disease E24881 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Lou Gehrig's disease | Statement: [Lou Gehrig, diseaseEponym, Lou Gehrig's disease]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Lou Gehrig's disease
Context triple: [Lou Gehrig, diseaseEponym, Lou Gehrig's disease]
  • A. Huntington's chorea
    Huntington's chorea is a hereditary neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and psychiatric symptoms, typically manifesting in mid-adulthood.
  • B. ALS chosen
    ALS (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and ultimately respiratory failure.
  • C. ALS
    ALS is a state-of-the-art synchrotron radiation facility at Lawrence Berkeley National Laboratory that produces intense X-ray and ultraviolet light for cutting-edge scientific research.
  • D. Parkinson's disease
    Parkinson's disease is a progressive neurodegenerative disorder characterized primarily by motor symptoms such as tremors, rigidity, and slowed movement, caused by the loss of dopamine-producing neurons in the brain.
  • E. spinal muscular atrophy
    Spinal muscular atrophy is a genetic neuromuscular disorder characterized by progressive muscle weakness and atrophy due to degeneration of motor neurons in the spinal cord.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: diseaseEponym
Context triple: [Lou Gehrig, diseaseEponym, Lou Gehrig's disease]
  • A. sharesEponymWith chosen
    Indicates that two entities are named after the same person, place, or thing (i.e., they share the same eponym).
  • B. speciesEponym
    Indicates that a species is named in honor of a particular person or entity.
  • C. diseaseType
    Indicates that one entity is classified as a specific type or category of disease in relation to another entity.
  • D. hasTargetDisease
    Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
  • E. diagnosedWith
    Indicates that a subject has been identified, typically by a medical professional, as having a particular disease or medical condition.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ab4c41e8c08190a9e8f5249cc12610 completed March 6, 2026, 9:50 p.m.
NER Named-entity recognition batch_69abdf881bbc81908987317b88b405d0 completed March 7, 2026, 8:19 a.m.
NED1 Entity disambiguation (via context triple) batch_69b01d91f6448190866f6ee0491041cf completed March 10, 2026, 1:33 p.m.
PD Predicate disambiguation batch_69abdd10aef88190b750aae07e7df4dc completed March 7, 2026, 8:08 a.m.
Created at: March 6, 2026, 10:02 p.m.